Camrelizumab Combined With Albumin-bound Paclitaxel and Platinum in Neoadjuvant Treatment of Resectable NSCLC
Clinical trial NCT04338620 · UNKNOWN
Trial details
- NCT number
- NCT04338620
- Sponsor
- Tang-Du Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-07
- Primary completion
- 2023-11-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.